When to Seek Clinical Guidance for GLP-1 Side Effects Mild nausea and stomach discomfort are expected during the first month of GLP-1 therapy and rarely require treatment discontinuation
Eli Lilly is currently studying retatrutide in several phase-3 clinical trials for obesity, type 2 diabetes, knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatosis liver disease
Koehler JA, Baggio LL, Yusta B, Longuet C, Rowland KJ, Cao X, et al
It has been shown to help users lose up to 33lbs (15.3kg) on average in around a year
S is calculated from estradiol by formula (2)